{"component": "definition", "props": {"groups": [{"snippet_links": [{"key": "section-42", "type": "clause", "offset": [28, 39]}, {"key": "this-agreement", "type": "clause", "offset": [43, 57]}], "samples": [{"hash": "i378NZ7PUrn", "uri": "/contracts/i378NZ7PUrn#validation-batch", "label": "Api Commercial Supply Agreement (Amarin Corp Plc\\uk)", "score": 33.1615333557, "published": true}, {"hash": "chOZDJF31ps", "uri": "/contracts/chOZDJF31ps#validation-batch", "label": "Api Commercial Supply Agreement", "score": 31.3408622742, "published": true}, {"hash": "kZ80ymDTNrO", "uri": "/contracts/kZ80ymDTNrO#validation-batch", "label": "Api Commercial Supply Agreement (Amarin Corp Plc\\uk)", "score": 22.6016426086, "published": true}], "snippet": "has the meaning provided in Section 4.2 of this Agreement.", "size": 4, "hash": "b933e6319dee5f5b98e497bff0d2a7db", "id": 1}, {"snippet_links": [{"key": "commercially-saleable", "type": "definition", "offset": [114, 135]}, {"key": "contained-in", "type": "definition", "offset": [141, 153]}, {"key": "paratek-product", "type": "definition", "offset": [165, 180]}], "samples": [{"hash": "dTLZJguaPhj", "uri": "/contracts/dTLZJguaPhj#validation-batch", "label": "Manufacturing Agreement (Paratek Pharmaceuticals, Inc.)", "score": 29.5831623077, "published": true}, {"hash": "kerzVVp5VCi", "uri": "https://investor.paratekpharma.com/static-files/81a7dd30-0a9d-42e7-a39d-8ed160017eb9", "label": "investor.paratekpharma.com", "score": 10.1704311371, "published": false}], "snippet": "means a batch or lot produced from a validation run. Each Validation Batch is intended to produce Product that is commercially saleable when contained in a finished Paratek Product.", "size": 4, "hash": "aadab7129e98ac8e9483f8af7292a6a9", "id": 2}, {"snippet_links": [{"key": "manufacturing-process", "type": "definition", "offset": [78, 99]}, {"key": "validation-studies", "type": "clause", "offset": [136, 154]}], "samples": [{"hash": "6abWTNQmCSO", "uri": "/contracts/6abWTNQmCSO#validation-batch", "label": "Development, Manufacturing and Supply Agreement (Celladon Corp)", "score": 26.3661880493, "published": true}, {"hash": "4hcg1UIx5vX", "uri": "/contracts/4hcg1UIx5vX#validation-batch", "label": "Development, Manufacturing and Supply Agreement (Celladon Corp)", "score": 26.2429847717, "published": true}], "snippet": "means a Batch that is produced with the intent to show reproducibility of the Manufacturing Process and is required to complete process validation studies.", "size": 4, "hash": "6cd195755023986cf1c60f761aa93ba0", "id": 3}, {"snippet_links": [{"key": "testing-and-documentation", "type": "clause", "offset": [28, 53]}, {"key": "this-agreement", "type": "clause", "offset": [82, 96]}], "samples": [{"hash": "91kaAnBFUSC", "uri": "/contracts/91kaAnBFUSC#validation-batch", "label": "Commercial Supply Agreement (Xeris Pharmaceuticals Inc)", "score": 29.4490070343, "published": true}, {"hash": "elLzdSpteo4", "uri": "/contracts/elLzdSpteo4#validation-batch", "label": "Commercial Supply Agreement (Xeris Pharmaceuticals Inc)", "score": 29.3915119171, "published": true}], "snippet": "means a Batch that requires testing and documentation beyond what is required per this Agreement.", "size": 2, "hash": "8f4b381b0a8723f0266e3258d24338a4", "id": 4}, {"snippet_links": [{"key": "gmp-batch", "type": "definition", "offset": [13, 22]}, {"key": "batch-size", "type": "clause", "offset": [37, 47]}, {"key": "the-process", "type": "clause", "offset": [70, 81]}], "samples": [{"hash": "lVwNTqGE82N", "uri": "/contracts/lVwNTqGE82N#validation-batch", "label": "Toll Manufacturing Agreement", "score": 31.3408622742, "published": true}, {"hash": "cpdeOxgtYpc", "uri": "/contracts/cpdeOxgtYpc#validation-batch", "label": "Toll Manufacturing Agreement (Oasmia Pharmaceutical AB)", "score": 26.4428482056, "published": true}], "snippet": "means a full GMP batch of a specific batch size that shall prove that the Process in use delivers batches of releasable quality in full accordance with specifications.", "size": 2, "hash": "4221b1e29c9f05447574bc47c8328530", "id": 5}, {"snippet_links": [{"key": "saleable-product", "type": "definition", "offset": [17, 33]}, {"key": "prior-to", "type": "definition", "offset": [47, 55]}, {"key": "nda-approval", "type": "definition", "offset": [56, 68]}, {"key": "the-process", "type": "clause", "offset": [85, 96]}, {"key": "commercial-scale", "type": "definition", "offset": [137, 153]}, {"key": "requirements-for", "type": "clause", "offset": [175, 191]}, {"key": "validation-process", "type": "definition", "offset": [194, 212]}], "samples": [{"hash": "fpfyP9uZqDn", "uri": "/contracts/fpfyP9uZqDn#validation-batch", "label": "Manufacturing and Supply Agreement (Sonus Pharmaceuticals Inc)", "score": 18.0, "published": true}, {"hash": "i4xdhNNZgEe", "uri": "https://ir.achievelifesciences.com/sec-filings/all-sec-filings/content/0000891020-02-001173/0000891020-02-001173.pdf", "label": "ir.achievelifesciences.com", "score": 11.0793972015, "published": false}], "snippet": "means a batch of saleable product manufactured prior to NDA approval to confirm that the process set forth in the NDA is reproducible at commercial scale, and which meets FDA requirements for a validation process.", "size": 2, "hash": "d5a0c64cc36b87eec598b7ab544b334c", "id": 6}, {"snippet_links": [{"key": "schedule-2", "type": "definition", "offset": [29, 39]}, {"key": "stage-8", "type": "definition", "offset": [41, 48]}], "samples": [{"hash": "fEoaF5Ixi5k", "uri": "/contracts/fEoaF5Ixi5k#validation-batch", "label": "Development and Manufacturing Agreement (Immucell Corp /De/)", "score": 21.6214923859, "published": true}], "snippet": "has the meaning set forth in Schedule 2, Stage 8. \u201cCommercialBatch\u201d xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx \u201cCommercial Campaign\u201d xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx", "size": 1, "hash": "ae86018b19d32288474d19129a31f426", "id": 7}, {"snippet_links": [{"key": "validation-protocol", "type": "definition", "offset": [82, 101]}, {"key": "as-agreed", "type": "clause", "offset": [102, 111]}, {"key": "in-writing", "type": "definition", "offset": [112, 122]}, {"key": "between-the-parties", "type": "clause", "offset": [123, 142]}, {"key": "according-to", "type": "definition", "offset": [165, 177]}, {"key": "in-accordance-with", "type": "clause", "offset": [218, 236]}, {"key": "good-manufacturing-practice", "type": "clause", "offset": [249, 276]}, {"key": "active-pharmaceutical-ingredients", "type": "definition", "offset": [290, 323]}, {"key": "without-limitation", "type": "clause", "offset": [357, 375]}, {"key": "commercial-manufacturing-process", "type": "definition", "offset": [490, 522]}, {"key": "filing-for-regulatory-approval", "type": "definition", "offset": [569, 599]}, {"key": "complete-the", "type": "clause", "offset": [633, 645]}, {"key": "stability-studies", "type": "clause", "offset": [677, 694]}, {"key": "in-connection-with", "type": "clause", "offset": [707, 725]}, {"key": "approval-of", "type": "definition", "offset": [814, 825]}, {"key": "equipment-change", "type": "clause", "offset": [872, 888]}, {"key": "with-respect-to", "type": "clause", "offset": [889, 904]}, {"key": "manufacture-of-product", "type": "clause", "offset": [920, 942]}, {"key": "this-exhibit", "type": "definition", "offset": [963, 975]}, {"key": "pursuant-to-a", "type": "clause", "offset": [994, 1007]}, {"key": "confidential-treatment-request", "type": "clause", "offset": [1008, 1038]}, {"key": "the-commission", "type": "clause", "offset": [1109, 1123]}], "samples": [{"hash": "5aHcJnOX4pj", "uri": "/contracts/5aHcJnOX4pj#validation-batch", "label": "Commercial Supply Agreement (Ironwood Pharmaceuticals Inc)", "score": 21.6050643921, "published": true}], "snippet": "means a batch of PRODUCT (a) that (i) conforms to the parameters described in the validation protocol as agreed in writing between the parties, (ii) is manufactured according to cGMP, as applicable, (iii) is validated in accordance with the ICH Q7A Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients (the \u201cICH Guidance\u201d) (including, without limitation, that such batch, together with two other such sequential batches of PRODUCT, demonstrates reproducibility of the commercial manufacturing process for PRODUCT), (iv) supports the NDA (or other filing for Regulatory Approval) for PRODUCT, (v) may be used to complete the consistency, comparability and stability studies for PRODUCT in connection with any such filing, and (vi) meets Specifications; or (b) supports a filing for Regulatory Approval of the implementation of a subsequent process or equipment change with respect to the commercial manufacture of PRODUCT. [**] = Portions of this exhibit have been omitted pursuant to a confidential treatment request. An unredacted version of this exhibit has been filed separately with the Commission.", "size": 1, "hash": "9da02a8180d023c215d6c097f8224a8f", "id": 8}, {"snippet_links": [{"key": "validation-batches", "type": "definition", "offset": [10, 28]}, {"key": "licensed-product", "type": "definition", "offset": [32, 48]}, {"key": "the-s", "type": "clause", "offset": [88, 93]}], "samples": [{"hash": "dQteWgejBDZ", "uri": "/contracts/dQteWgejBDZ#validation-batch", "label": "License Agreement (Harrow, Inc.)", "score": 36.1642723083, "published": true}], "snippet": "means the validation batches of Licensed Product manufactured by S\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 under the S\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 MSA.", "size": 1, "hash": "124a02129bec547da0ae2ef0f03f8eb1", "id": 9}, {"snippet_links": [], "samples": [{"hash": "8s1TMJ4e9DA", "uri": "/contracts/8s1TMJ4e9DA#validation-batch", "label": "Commercial Supply Agreement (Cogent Biosciences, Inc.)", "score": 37.8432580424, "published": true}], "snippet": "has the meaning set forth in Section 2.9", "size": 1, "hash": "8c5721ef77dc1d6a0883e86b2ce3f1e4", "id": 10}], "next_curs": "Cl0SV2oVc35sYXdpbnNpZGVyY29udHJhY3RzcjkLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIZdmFsaWRhdGlvbi1iYXRjaCMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"title": "Validation Batch", "snippet": "has the meaning provided in Section 4.2 of this Agreement.", "size": 26, "id": "validation-batch", "examples": ["Activity 8: Validation Reports 20 working days after completion of <strong>Validation Batch</strong> #3, or 20 days from date requested by RADIUS Activity 9: Validation Stability Stability study to start within one month of batch purification and continue according to protocol Activity 10: DMF Filing Within 40 working days of date requested by RADIUS, but not earlier than 3.5 months after the end of the Validation Campaign.", "ACP will complete <strong>Validation Batch</strong> #1, <strong>Validation Batch</strong> #2 and <strong>Validation Batch</strong> #3 for one indication as described in Exhibit A to the Master Service Agreement entered into by parties as of January 28, 2015 as of the Effective Date.", "The foregoing remedy shall be Indivior&#x27;s sole and exclusive remedy for any failure of a <strong>Validation Batch</strong> to conform to the Manufacturing Standards.", "In the event that Anthra determines that any <strong>Validation Batch</strong> does not conform to the Specifications or the CMC, Anthra shall give Sicor notice of its rejection thereof (including a sample from the batch analyzed) within forty-five (45) days after receipt of such <strong>Validation Batch</strong>.", "For each <strong>Validation Batch</strong> and upon request for Production Batches of the Drug manufactured for ORPHAN hereunder, Supplier shall furnish to ORPHAN at the time of its delivery copies of the following records.", "Nisso shall provide to Replidyne (i) written notice of its release of the relevant <strong>Validation Batch</strong>, (ii) a certificate of analysis for such <strong>Validation Batch</strong>, (iii) the results of all relevant testing data for such <strong>Validation Batch</strong>, and (iv) samples of such <strong>Validation Batch</strong> for Replidyne\u2019s independent testing, which shall be reasonably satisfactory to Replidyne and Replidyne shall pay Nisso the reasonable shipping cost of such samples separately.", "PYRAMID will produce a <strong>Validation Batch</strong> only upon the written request of Client submitted in a Purchase Order.", "In the event that Anthra shall give Sicor such notice, then Anthra shall make payment for such <strong>Validation Batch</strong> within thirty days after receipt by Anthra of notice, if any, from the Testing Laboratory that the <strong>Validation Batch</strong> is conforming.", "Each <strong>Validation Batch</strong> shall be shipped for final formulation to a facility in the United States to be mutually agreed by Anthra and Vinchem.", "Supplier and ORPHAN will jointly review all process development and analytical test results, the Validation Protocol, and stability study results prior to manufacture of each <strong>Validation Batch</strong>."], "related": [["batch", "Batch", "Batch"], ["validation", "Validation", "Validation"], ["drug-substance", "Drug Substance", "Drug Substance"], ["open-type-traction-battery", "Open type traction battery", "Open type traction battery"], ["bulk-drug-substance", "Bulk drug substance", "Bulk drug substance"]], "related_snippets": [], "updated": "2026-11-07T04:22:58+00:00"}, "json": true, "cursor": ""}}